Snipr Biome to collaborate with US cancer hospital
The Danish company will examine the effect of new CRISPR therapies as a treatment for immune therapy side effects alongside the MD Anderson Cancer Center.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Biotech company Snipr Biome has found a partner to help develop new treatments using CRISPR technology, which targets the human microbiome.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
